Recent Posts

Monday Morning Recap: The Week (1.19.15-1.25.15) in Drug & Device Law & Policy

Filed in Monday Morning Recap by on January 26, 2015 0 Comments
Monday Morning Recap: The Week (1.19.15-1.25.15) in Drug & Device Law & Policy

Another Monday, another Monday Morning Recap, the post where we call out recent drug and device law and policy developments that caught our eye and made us think. We hope you find it helpful (and that you’ll feel free to reach out–kate.greenwood@shu.edu–if there are ways we could improve it). The forecast calls for a blizzard […]

Continue Reading »

Recommended Reading: New Empirical Analysis of False Claims Act Whistleblower Litigation

Filed in Recommended Reading by on January 23, 2015 0 Comments
Recommended Reading: New Empirical Analysis of False Claims Act Whistleblower Litigation

By Kate Greenwood Cross-Posted at Bill of Health Late last year, the Columbia Law Review published David Freeman Engstrom’s Private Enforcement’s Pathways: Lessons from Qui Tam Litigation, the fourth in a series of articles Professor Engstrom has written on the growth and evolution of qui tam litigation. (My colleague Associate Dean Kathleen Boozang wrote about […]

Continue Reading »

Speakers Announced for Upcoming SHU Law Behavioral Health Conference

Filed in Events by on January 21, 2015 0 Comments
Speakers Announced for Upcoming SHU Law Behavioral Health Conference

Here’s the flyer for another great, free conference here at Seton Hall Law. This one will be held February 6th and will focus on insurance coverage of mental health and substance abuse treatment.

Continue Reading »

Monday Morning Recap: The Week (1.2.15-1.18.15) in Drug & Device Law & Policy

Filed in Monday Morning Recap by on January 20, 2015 0 Comments
Monday Morning Recap: The Week (1.2.15-1.18.15) in Drug & Device Law & Policy

Here’s the Monday Morning Recap, this week on Tuesday due to the holiday, the post where we call out recent drug and device law and policy developments that caught our eye and made us think. We hope you find this week’s Recap of interest! 1. Last week, the Food and Drug Administration released a report […]

Continue Reading »

A “Money Blind” for Research into Maternal-Fetal Medication Risk?

Filed in Conflicts of Interest, Drugs & Devices by on January 16, 2015 0 Comments
A “Money Blind” for Research into Maternal-Fetal Medication Risk?

By Kate Greenwood Cross-Posted at Bill of Health A week ago, the Food and Drug Administration announced the results of a review of the medical literature it conducted in response to “recent reports questioning the safety of prescription and over-the-counter (OTC) pain medicines when used during pregnancy.” The literature, FDA determined, is inconclusive. FDA found […]

Continue Reading »